Literature DB >> 9819870

Pregnancy outcomes in women treated with elective versus ultrasound-indicated cervical cerclage.

E R Guzman1, J K Forster, A M Vintzileos, C V Ananth, C Walters, K Gipson.   

Abstract

OBJECTIVE: To compare pregnancy outcomes in women at risk for pregnancy loss treated with elective versus ultrasound-indicated placement of cerclage.
METHODS: A retrospective cohort study was performed on two groups of patients with singleton gestations. The first group consisted of women at risk for pregnancy loss who were treated with an elective cerclage, while the second group was managed conservatively and followed with serial transvaginal cervical sonography and transfundal pressure. An emergency cerclage was placed in women in the second group when the endocervical canal length shortened to < 20 mm, either spontaneously or in response to transfundal pressure. The two groups were compared with respect to maternal demographics, obstetric and gynecological history, and gestational age, both at time of cerclage placement and delivery.
RESULTS: A total of 138 patients were identified. Eighty-one patients were treated with an elective cerclage and 57 with an ultrasound-indicated cerclage. Patients treated with elective cerclages were older (32 versus 27 years, p = 0.0003), more commonly white (56.8% versus 38.6%, p = 0.0380), less commonly nulliparous (23.5% versus 43.9%, p = 0.0063), and more often private patients (92.6% versus 28.1%, p < 0.0001). A history of previous treatment with cerclage (45.7% versus 10.5%, odds ratio (OR) 0.2, 95% confidence interval (CI) 0.1-0.4) and one prior midtrimester loss (53.1% versus 33.3%, OR 0.4, 95% CI 0.2-0.9) were also more common in the elective versus ultrasound-indicated cerclage group. However, there was no difference in the rates of previous preterm delivery, two midtrimester losses, two terminations of pregnancy, in utero diethylstilbestrol exposure, uterine anomalies, history of cone biopsy or parity. As expected, gestational age at placement of cerclage was significantly earlier in the elective group (13.0 versus 20.0 weeks, p < 0.0001). The median (range) gestational age at delivery (37 (15-41) versus 37 (17-41) weeks, p = 0.90), the number of early (< 25 weeks) losses (9.9% versus 8.8%, OR 1.6, 95% CI 0.3-7.9), and preterm deliveries (< 37 weeks) (35.8% versus 36.8%, OR 1.1, 95% CI 0.4-3.2) were similar in the elective and ultrasound-indicated cerclage patients, respectively.
CONCLUSION: In patients at risk for pregnancy loss, placement of cervical cerclages in response to ultrasonographically detected shortening of the endocervical canal length is a medically acceptable alternative to the use of elective cerclage.

Entities:  

Mesh:

Year:  1998        PMID: 9819870     DOI: 10.1046/j.1469-0705.1998.12050323.x

Source DB:  PubMed          Journal:  Ultrasound Obstet Gynecol        ISSN: 0960-7692            Impact factor:   7.299


  10 in total

Review 1.  The role of cervical cerclage in obstetric practice: can the patient who could benefit from this procedure be identified?

Authors:  Roberto Romero; Jimmy Espinoza; Offer Erez; Sonia Hassan
Journal:  Am J Obstet Gynecol       Date:  2006-01       Impact factor: 8.661

Review 2.  Recurrent preterm birth.

Authors:  Shali Mazaki-Tovi; Roberto Romero; Juan Pedro Kusanovic; Offer Erez; Beth L Pineles; Francesca Gotsch; Pooja Mittal; Nandor Gabor Than; Jimmy Espinoza; Sonia S Hassan
Journal:  Semin Perinatol       Date:  2007-06       Impact factor: 3.300

3.  Evidence that antibiotic administration is effective in the treatment of a subset of patients with intra-amniotic infection/inflammation presenting with cervical insufficiency.

Authors:  Kyung Joon Oh; Roberto Romero; Jee Yoon Park; JoonHo Lee; Agustin Conde-Agudelo; Joon-Seok Hong; Bo Hyun Yoon
Journal:  Am J Obstet Gynecol       Date:  2019-03-28       Impact factor: 8.661

Review 4.  Is sonographic assessment of the cervix necessary and helpful?

Authors:  Joel D Larma; Jay D Iams
Journal:  Clin Obstet Gynecol       Date:  2012-03       Impact factor: 2.190

Review 5.  Vaginal progesterone vs. cervical cerclage for the prevention of preterm birth in women with a sonographic short cervix, previous preterm birth, and singleton gestation: a systematic review and indirect comparison metaanalysis.

Authors:  Agustin Conde-Agudelo; Roberto Romero; Kypros Nicolaides; Tinnakorn Chaiworapongsa; John M O'Brien; Elcin Cetingoz; Eduardo da Fonseca; George Creasy; Priya Soma-Pillay; Shalini Fusey; Cetin Cam; Zarko Alfirevic; Sonia S Hassan
Journal:  Am J Obstet Gynecol       Date:  2012-11-15       Impact factor: 8.661

6.  Patients with acute cervical insufficiency without intra-amniotic infection/inflammation treated with cerclage have a good prognosis.

Authors:  Max Mönckeberg; Rafael Valdés; Juan P Kusanovic; Manuel Schepeler; Jyh K Nien; Emiliano Pertossi; Pablo Silva; Karla Silva; Pía Venegas; Ulises Guajardo; Roberto Romero; Sebastián E Illanes
Journal:  J Perinat Med       Date:  2019-07-26       Impact factor: 2.716

7.  A comparison of emergency and therapeutic modified Shirodkar cerclage: an analysis of 38 consecutive cases.

Authors:  Alper Başbuğ; Ozan Doğan
Journal:  Turk J Obstet Gynecol       Date:  2019-03-27

8.  Outcomes following Placement and Removal of Transvaginal Cerclage in at Risk Pregnancies: A Single Center Experience.

Authors:  Henry Adekola; Jennifer Addo; Elizabeth Ramsey Unal; Emma James; Vivek Prakash; Robert Abrams
Journal:  J Pregnancy       Date:  2022-07-13

9.  Personalized assessment of cervical length improves prediction of spontaneous preterm birth: a standard and a percentile calculator.

Authors:  Dereje W Gudicha; Roberto Romero; Doron Kabiri; Edgar Hernandez-Andrade; Percy Pacora; Offer Erez; Juan Pedro Kusanovic; Eunjung Jung; Carmen Paredes; Stanley M Berry; Lami Yeo; Sonia S Hassan; Chaur-Dong Hsu; Adi L Tarca
Journal:  Am J Obstet Gynecol       Date:  2020-09-09       Impact factor: 8.661

Review 10.  Adjuvant 17-hydroxyprogesterone caproate in women with history-indicated cerclage: A systematic review and meta-analysis.

Authors:  Ahizechukwu C Eke; Jeanne Sheffield; Ernest M Graham
Journal:  Acta Obstet Gynecol Scand       Date:  2018-11-18       Impact factor: 4.544

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.